NSPR News and Press, InspireMD Inc. From 01/18/22

TEL AVIV, Israel, Jan. 18, 2022 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for prevention of stroke caused by Carotid Artery Disease (CAD), today announced that a live case demonstration featuring CGuard™ ...

InspireMD, Inc. (NSPR) Q3 2021 Earnings Conference Call November 9, 2021 08:30 a.m. ET Company Representatives Marvin Slosman - Chief Executive Officer Craig Shore - Chief Financial Officer David Holmes - LifeSci Advisors Conference Call Participants Ben Haynor - Alliance Global Partners Pres...

InspireMD (NASDAQ:NSPR): Q3 GAAP EPS of -$0.53 beats by $0.24. Revenue of $1.07M (+9.2% Y/Y) misses by $0.23M. Press Release For further details see: InspireMD EPS beats by $0.24, misses on revenue

-CGuard™ sales generated 24% YoY revenue growth- -CGuard™ EPS received a positive opinion from the French National Authority for Health (HAS) regarding reimbursement in France- - $37.1 million in cash, cash equivalents and short-term bank deposits as of...

InspireMD (NASDAQ:NSPR) is scheduled to announce Q3 earnings results on Tuesday, November 9th, before market open. The consensus EPS Estimate is -$0.82 and the consensus Revenue Estimate is $1.2M (+22.4% Y/Y). Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward. ...

ADT,AGEN,AGTC,ALLT,APRN,AUD,OTCPK:BAYZF,BHVN,BNTX,BSY,CAH,CANO,CCO,CEVA,CNCE,CORR,DCTH,DHI,DRNA,EBIX,ECOM,EGRX,EPZM,EXK,FOLD,GILT,GLNG,GOL,HAE,HAIN,HGV,HUYA,IGT,IIVI,INSW,ISEE,ITCI,KNDI,KPLT,MIDD,MLCO,MNTV,MRNS,MRSN,MSGE,OTCPK:NSANY,NSPR,NUWE,OCGN,OESX,OSG,OWL,PLTR,PRPL,PRTY,QTNT,SATS,SEAS,SE...

TEL AVIV, Israel, Nov. 03, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced that results from the investigator-initia...

TEL AVIV, Israel, Oct. 26, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announces it will report third quarter 2021 financi...

3 Hot Penny Stocks to Add to Your October Watchlist Investing in penny stocks in 2021 has not been easy. And with no signs of easing on volatility anytime soon, investors should be constantly adjusting their strategies. With penny stocks , we tend to see speculation play a much larg...

TEL AVIV, Israel, Oct. 13, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), a global developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announced that its CGuard EPS stent system...